U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 6281 - 6290 of 12702 results

Status:
Possibly Marketed Outside US
Source:
UK NHS:Benperidol
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Benperidol is a relatively old antipsychotic drug that has been marketed since 1966. It has been used in Germany for 30 years, but is also available in Belgium, Greece, Italy, the Netherlands and the UK. Benperidol is a drug which is a highly potent butyrophenone derivative. It is the most potent neuroleptic on the European market, with chlorpromazine equivalency as high as 75 to 100 (about 150 to 200% potency in terms of dose compared to haloperidol). Benperidol was discovered at Janssen Pharmaceutica in 1961. Benperidol is a potent dopamine receptor antagonist, with a high affinity for the D2-sites. The antipsychotic effects of this drug are primarily due to blockade of the D receptors. In terms of D receptor blockade, benperidol is one of the most potent antipsychotic agents, being approximately eight times more potent than haloperidol. Benperidol also acts as a dopamine antagonist in the chemoreceptor trigger zone, giving rise to antiemetic properties. It is also a weak antagonist at muscarinic, histamine H1, and alpha1-adrenoceptors. Adverse effects include extrapyramidal side effects and tardive dykinesia
Status:
Possibly Marketed Outside US
Source:
Japan:Sulfamethopyrazine
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)



Sulfalene (INN, USAN) or Sulfametopyrazine (BAN) is a long-acting sulfonamide antibiotic used for the treatment of chronic bronchitis, urinary tract infections, and malaria. Sulfametopyrazine, by virtue of a long half-life, achieves peak blood levels of 120 mkg/ml or more which fall to around 30-50 mkg/ml one week after a single oral dose of 2 g. Long-term administration of this drug in the treatment of leprosy for up to 3 years has been accomplished without serious unwanted effects
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (RACEMIC)

Piprozolin is a choleretic drug. It was marketed under tradenames Probilin, Secrebil, Prozobil for the treatment of biliary-tract disorders and dyspepsia.
Status:
Possibly Marketed Outside US
Source:
UK NHS:Aminoacridine hydrochloride
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Status:
Possibly Marketed Outside US
Source:
Canada:METHENAMINE MANDELATE
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Status:

Class (Stereo):
CHEMICAL (ACHIRAL)

Conditions:

Coumaphos is an organophosphate insecticide used against ectoparasites. It was approved by FDA for the control of gastrointestinal roundworms in cattle (Purina brand name). It was also used in medicated feed against internal parasites (Ascaidia galli, Capilleria obsignata and Heterakis gallinarum) in layer chickens (Meldane brand name). However, coumaphos is highly toxic to birds. Sever acute toxicity and eventual death were caused in hens after they were given oral doses of 10mg/kg for 1-8 days.The oral LD50 for coumaphos is 3mg/kg in wildbirds, 29.4mg/kg in mallard ducks, 7.94mg/kg in pheasants and 14mg/kg in chicken. Due to its toxicity, coumaphos is no longer available as a drug.
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (ACHIRAL)

Succinimide a chemical compound used in different organic syntheses. Succinimides are compounds that contain the succinimide group, a pharmacophore, responsible for the anticonvulsant effect. Succinimides used to control certain seizures in the treatment of epilepsy, by acting on the central nervous system.
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (ACHIRAL)

Conditions:

BUTETHAMINE, an ester of the para-aminobenzoic acid, is a local anesthetic formerly used in dentistry. It has diminished toxicity and increased the speed of action as compared with procaine.
Status:
Possibly Marketed Outside US
Source:
Japan:Androstenediol
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)



This compound belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. The value of Δ5-diol as a radiation countermeasure is based mainly on its stimulation of production of white blood cells and platelets. Androstenediol used by the body to make testosterone and estrogen. There is some concern that androstenediol might increase the risk of coronary heart disease. There is also developing evidence that androstenediol might help prostate cancer cells grow. Taking androstenediol along with estrogen and testosterone pills might cause too much estrogen or testosterone in the body.
Oxitriptan is an aromatic amino acid with antidepressant activity. In vivo, oxitriptan is converted into 5-hydroxytryptamine (serotonin) as well as other neurotransmitters. Oxitriptan may exert its antidepressant activity via conversion to serotonin or directly by binding to serotonin receptors within the central nervous system. It is used as an antiepileptic and antidepressant. Oxitriptan is a worthwhile addition to the limited treatments available for obsessive-compulsive disorder and panic disorder, two psychiatric disorders which have previously been difficult to manage pharmacologically. Possible gastrointestinal side effects are: nausea, vomiting, abdominal pain, constipation or flatulence, which tend to disappear with continued treatment or, in any case, dose reduction. Other undesirable effects such as anorexia, xerostomia, tachycardia, extrasystoles, dizziness, headache, lightheadedness, tremor or myalgia may occur.

Showing 6281 - 6290 of 12702 results